A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes.
Alam Q, ZubairAlam M, Karim S, Gan SH, Kamal MA, Jiman-Fatani A, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Haque A.
Alam Q, et al. Among authors: kamal ma.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):478-86. doi: 10.2174/18715273113126660159.
CNS Neurol Disord Drug Targets. 2014.
PMID: 24059303
Review.